Issues related to 2024 Farm Bill; general agriculture; animal health; regulatory processes; OneHealth; and USDA programs
Issues related to FY25 appropriations for animal health programs and drug compounding
Duration: March 1, 2021
to
present
General Issues: Agriculture , Budget/Appropriations , Defense
Spending: about $620,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2021: U.S. Senate, House of Representatives, Agriculture - Dept of (USDA), Environmental Protection Agency (EPA)
Related Foreign Entities:
Boehringer Ingelheim International GmbH (Ingelheim am Rheim , GER); contribution to lobbying: $0; ownership 100%
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
T.A. Hawks Minority Staff Director, Senate Committee on Agriculture, Nutrition, and Forestry; Chief of Staff, Legislative Director, Legislative Assistant, Deputy Legislative Director, Legislative Aide, U.S. Senator Thad Cochran (R-MS)
Lilia McFarland Horder Acting Chief of Staff, Departmental Administration, USDA, Acting Chief of Staff, Office of the Deputy Secretary, USDA, Legislative Fellow (Detailed from USDA), Office of Senator Dianne Feinstein, Special Assistant
John Weber Legislative Director, Senior Policy Advisor, U.S. Rep. Dusty Johnson (R-SD); Legislative Assistant, Chairman Conaway, House Committee on Agriculture, Staff Assistant, U.S. Rep. Kristi Noem (R-SD).
Poorvie Bishnoi n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, Monument Advocacy lobbied for Boehringer Ingelheim USA Corporation , earning $50,000. The report was filed on April 22.
Original Filing: 301570376.xml
Lobbying Issues
Issues related to 2024 Farm Bill; general agriculture; animal health; regulatory processes; OneHealth; and USDA programs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to FY25 appropriations for animal health programs and drug compounding
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, Monument Advocacy lobbied for Boehringer Ingelheim USA Corporation , earning $50,000. The report was filed on Jan. 22.
Original Filing: 301535503.xml
Lobbying Issues
Issues related to 2023 Farm Bill; general agriculture; animal health; regulatory processes; OneHealth; the Animal Drug User Fee Act; and USDA programs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to FY24 appropriations for animal health programs and drug compounding
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, Monument Advocacy lobbied for Boehringer Ingelheim USA Corporation , earning $50,000. The report was filed on Oct. 20, 2023.
Original Filing: 301510357.xml
Lobbying Issues
Issues related to 2023 Farm Bill; general agriculture; animal health; regulatory processes; OneHealth; the Animal Drug User Fee Act; and USDA programs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to FY24 appropriations for animal health programs and drug compounding
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to the FY24 NDAA and prevention of foreign animal diseases for food security.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2023
In Q2, Monument Advocacy lobbied for Boehringer Ingelheim USA Corporation , earning $50,000. The report was filed on July 20, 2023.
Original Filing: 301485817.xml
Lobbying Issues
Issues related to 2023 Farm Bill; general agriculture; animal health; regulatory processes; OneHealth; the Animal Drug User Fee Act; and USDA programs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to FY24 appropriations for animal health programs and drug compounding
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, Monument Advocacy lobbied for Boehringer Ingelheim USA Corporation , earning $50,000. The report was filed on April 20, 2023.
Original Filing: 301460316.xml
Lobbying Issues
Issues related to 2023 Farm Bill; general agriculture; animal health; regulatory processes; OneHealth; and, USDA programs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to FY24 appropriations for animal health programs.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, Monument Advocacy lobbied for Boehringer Ingelheim USA Corporation , earning $50,000. The report was filed on Jan. 20, 2023.
Original Filing: 301436855.xml
Lobbying Issues
Issues related to general agriculture; animal health; regulatory processes; OneHealth; and, USDA programs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to FY 2023 appropriations; H.R. 8239 - Agriculture, Rural Development, Food and Drug Administration, Related Agencies Appropriations Act, 2023, and H.R. 2617 - Consolidated Appropriations Act of 2023.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to animal health; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023; S. 4543 - James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, Monument Advocacy lobbied for Boehringer Ingelheim USA Corporation , earning $50,000. The report was filed on Oct. 20, 2022.
Original Filing: 301417322.xml
Lobbying Issues
Issues related to general agriculture; animal health; regulatory processes; OneHealth; and, USDA programs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to FY 2023 appropriations; H.R. 8239 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to animal health; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023; S. 4543 - James M. Inhofe National Defense Authorization Act for Fiscal Year 2023
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, Monument Advocacy lobbied for Boehringer Ingelheim USA Corporation , earning $50,000. The report was filed on July 20, 2022.
Original Filing: 301390262.xml
Lobbying Issues
Issues related to general agriculture; animal health; regulatory processes; OneHealth; and, USDA programs.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to FY 2023 appropriations; H.R. 8239 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2023.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to animal health; FY23 National Defense Authorization Act; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023.
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, Monument Advocacy lobbied for Boehringer Ingelheim USA Corporation , earning $50,000. The report was filed on April 20, 2022.
Original Filing: 301368001.xml
Lobbying Issues
Issues related to general agriculture issues; animal health; regulatory processes; OneHealth; USDA programs; and, pesticide programs
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to FY 2022 appropriations; S. 2599, H.R. 4356, and H.R. 4502 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to animal health; FY23 National Defense Authorization Act
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, Monument Advocacy lobbied for Boehringer Ingelheim USA Corporation , earning $50,000. The report was filed on Jan. 20, 2022.
Original Filing: 301331844.xml
Lobbying Issues
Issues related to general agriculture issues; animal health; regulatory processes; COVID-19; OneHealth
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to FY 2022 appropriations; S. 2599, H.R. 4356, and H.R. 4502 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Agencies Lobbied
U.S. Senate
Lobbying Issues
National Defense Authorization Act; Issues related to animal health; H.R.4350 and S. 2792 - National Defense Authorization Act for Fiscal Year 2022
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, Monument Advocacy lobbied for Boehringer Ingelheim USA Corporation , earning $50,000. The report was filed on Oct. 20, 2021.
Original Filing: 301310530.xml
Lobbying Issues
Issues related to general agriculture issues; animal health; regulatory processes; COVID-19; OneHealth
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to FY 2022 appropriations; S. 2599, H.R. 4356, and H.R. 4502 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2022
Agencies Lobbied
U.S. Senate
Lobbying Issues
National Defense Authorization Act; Issues related to animal health; H.R.4350 and S. 2792 - National Defense Authorization Act for Fiscal Year 2022
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, Monument Advocacy lobbied for Boehringer Ingelheim USA Corporation , earning $50,000. The report was filed on July 20, 2021.
Original Filing: 301284423.xml
Lobbying Issues
Issues related to general agriculture issues; animal health; regulatory processes; COVID-19
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to FY 2022 appropriations
Agencies Lobbied
U.S. Senate
Lobbying Issues
National Defense Authorization Act; Issues related to animal health
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, Monument Advocacy lobbied for Boehringer Ingelheim USA Corporation , earning $20,000. The report was filed on April 20, 2021.
Original Filing: 301260673.xml
Lobbying Issues
Issues related to general agriculture issues; animal health; regulatory processes; COVID-19
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to FY 2022 appropriations
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
Monument Advocacy filed a lobbying registration on April 6, 2021 to represent Boehringer Ingelheim USA Corporation, effective March 1, 2021.
Original Filing: 301250843.xml
Issue(s) they said they’d lobby about: Issues related to general agriculture issues, animal health, regulatory processes, COVID-19, appropriations .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...